Erratum: Exosomal-miR-1184 derived from mesenchymal stem cells alleviates cisplatin-associated acute kidney injury (Molecular Medicine Reports (2021) 24 (795) DOI: 10.3892/mmr.2021.12435)

1Citations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.
Get full text

Abstract

Subsequently to the publication of this paper, the authors have noticed that Fig. 5 was published with inadvertent errors; essentially, the y-axis label in Fig. 5D should have read "TNF -α" instead of "IL -1β" and conversely, in Fig. 5E, the y-axis label should have read "IL -1β" instead of "TNF -α". The revised version of Fig. 5, with Figs. 5D and E now labelled correctly, is shown below. Note that these errors did not significantly affect either the results or the conclusions reported in this paper, and all the authors agree to this corrigendum. Furthermore, the authors thank the Editor of Molecular Medicine Reports for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused.

Cite

CITATION STYLE

APA

Zhang, J., He, W., Zheng, D., He, Q., Tan, M., & Jin, J. (2022, July 1). Erratum: Exosomal-miR-1184 derived from mesenchymal stem cells alleviates cisplatin-associated acute kidney injury (Molecular Medicine Reports (2021) 24 (795) DOI: 10.3892/mmr.2021.12435). Molecular Medicine Reports. Spandidos Publications. https://doi.org/10.3892/mmr.2022.12757

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free